Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Buffers and Standards
  4. Chromatography Standards
  5. Drug Standards
  6. 111015394

Cilostazol Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™

Catalog No. 111015394
Click to view available options
Quantity:
1 g

Description

Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. Cilostazol is a dihydro-quinolinone derivative, that is predominantly used as an anti-platelet and vasodilatory agent. It acts by inhibition of cyclic adenosine monophosphate (cAMP) phosphodiesterase, which results in elevation of cAMP levels in platelets and blood vessels, thus inhibiting platelets aggregation. Featured Industries: Pharmaceutical (small molecule)
TRUSTED_SUSTAINABILITY

Specifications

CAS 73963-72-1
Purity Grade Notes These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.
Linear Formula C20H27N5O2
MDL Number MFCD00866780
Synonym Cilostazol; 6-[4-(1-Cyclohexyl-1 H-tetrazol-5-yl)-butoxy]-3,4-dihydro-2(1 H)-quinolinone; OPC 13013; OPC 21; Pletaal
Type Certified Reference Material
Quantity 1 g
Formula Weight 369.46
Grade Certified Reference Material
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.